Clinical trial
A Randomized, Double-blind, Sham-controlled Pivotal Study of Sensory Stimulation in Subjects With Alzheimer's Disease (HOPE Study)
NCT05637801 is registered in ClinicalTrials.gov with Cognito Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Sham-controlled Pivotal Study of Sensory Stimulation in Subjects With Alzheimer's Disease (HOPE Study)
- Lead sponsor
- Cognito Therapeutics, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 13, 2022
- Completion date
- August 17, 2026
- Enrollment
- 673 (actual)
- Sites
- 68
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer disease, alzheimer disease 1, alzheimer disease 10, alzheimer disease 11, alzheimer disease 12, alzheimer disease 13, alzheimer disease 14, alzheimer disease 15, alzheimer disease 16, alzheimer disease 17, alzheimer disease 18, alzheimer disease 19, alzheimer disease 2, alzheimer disease 3, alzheimer disease 4, alzheimer disease 5, alzheimer disease 6, alzheimer disease 7, alzheimer disease 8, alzheimer disease 9, alzheimer disease, early onset, alzheimer disease, late onset, alzheimer's dementia late onset, cognitive decline, cognitive impairment, cognitive impairment, mild, dementia, dementia alzheimers, dementia moderate, dementia of alzheimer type, dementia senile, dementia, mild, mci, mild cognitive impairment, mild dementia